vascular dementia: A degenerative vascular disorder affecting the brain. It is caused by the blockage of the blood supply to the brain. It is manifested with decline of memory and cognitive functions.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
1691 |
4. Check minimum number of eventsNone |
1691 |
5. Include endpointsNone |
1691 |
6. Filter based on genotype QC (FinnGen only) |
1691 |
Control definitions (FinnGen only)
- Control exclude
- F5_DEMENTIA, G6_ALZHEIMER, G6_AD_WIDE
Extra metadata
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- F01
- Name in latin
- Dementia vascularis non specificata
Similar endpoints
↥List of similar endpoints to
Vascular dementia (undefined)
based on the number of shared cases.
Similar with more cases:
- Vascular dementia
- Any dementia
- Any dementia, excluding more controls
- Dementia
- Dementia, including avohilmo
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 32388 | 19286 | 12580 |
| Only index persons | 20944 | 12781 | 8163 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.47 | 0.55 | 0.35 |
| Only index persons | 0.41 | 0.47 | 0.31 |
| Median age at first event (years) | |||
| Whole population | 84.37 | 85.85 | 82.22 |
| Only index persons | 85.25 | 86.78 | 82.86 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1691 | 622 | 1069 |
| Unadjusted period prevalence (%) | 0.38 | 0.21 | 0.47 |
| Median age at first event (years) | 82.41 | 84.28 | 81.32 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1468
- Matched controls
- 14573
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F03
ICD-10 Finland
Unspecified dementia
62.9
323.0
392
84
F01.9
ICD-10 Finland
Vascular dementia, unspecified
4503599627370496.0
323.0
1466
20
N05AX08
ATC
risperidone; systemic
13.1
198.5
375
373
N06DX01
ATC
memantine; oral
74.5
192.2
218
34
N06DA02
ATC
donepezil; oral
92.6
163.1
180
22
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
5.2
123.1
447
1123
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
+∞
122.3
116
*
N05AH04
ATC
quetiapine; oral
7.5
121.8
316
515
G30.1
ICD-10 Finland
Alzheimer disease with late onset
38.0
108.4
139
40
F01
ICD-10 Finland
Vascular dementia
119.5
94.0
101
9
R53
ICD-10 Finland
Malaise and fatigue
3.6
91.6
528
1961
F01.0
ICD-10 Finland
Vascular dementia of acute onset
+∞
86.1
82
*
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
3.4
79.8
481
1813
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
5.6
79.1
253
523
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
167.8
76.6
80
5
F01.19
ICD-10 Finland
Multi-infarct dementia without information on additional symptoms
+∞
69.1
66
*
P20
ICPC
Memory disturbance
3.8
67.3
331
1040
N06DA03
ATC
rivastigmine; oral, transdermal
51.7
65.8
79
16
R41.0
ICD-10 Finland
Disorientation, unspecified
6.6
62.2
169
280
G30.8
ICD-10 Finland
Other Alzheimer disease
61.6
60.9
71
12
F01.20
ICD-10 Finland
Subcortical vascular dementia without additional symptoms
64.2
58.7
68
11
N06DA04
ATC
galantamine; oral
59.3
53.8
63
11
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.4
52.2
630
3454
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.3
49.3
690
4037
F01.10
ICD-10 Finland
Multi-infarct dementia without additional symptoms
133.7
49.0
52
*
F01.29
ICD-10 Finland
Subcortical vascular dementia without information on additional symptoms
251.4
48.2
49
*
F05.1
ICD-10 Finland
Delirium superimposed on dementia
43.5
47.7
59
14
N06AB04
ATC
citalopram; systemic
2.7
46.1
377
1645
N05AD01
ATC
haloperidol; systemic
5.5
44.9
141
278
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
4.9
44.8
156
345
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
3.2
44.7
262
917
N03AG01
ATC
valproic acid; systemic, rectal
7.0
43.1
111
169
AA1AD
NOMESCO Finland
CT of head and brain
2.4
42.8
457
2297
F00.20*G30.8
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms
32.1
40.2
53
17
N06AX11
ATC
mirtazapine; oral
2.3
39.2
437
2228
P70
ICPC
Dementia
11.7
38.3
72
64
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.3
37.5
422
2150
A06AD11
ATC
lactulose; oral
2.3
37.4
461
2455
F00.10*G30.1
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
37.0
36.9
47
13
I67.3
ICD-10 Finland
Progressive vascular leukoencephalopathy
10.8
36.4
71
68
A28
ICPC
Limited function/disability NOS
2.3
35.6
389
1947
SPAT1053
SPAT
Memory test
2.5
34.0
319
1472
N05BA04
ATC
oxazepam; oral
2.2
33.4
400
2080
F01.1
ICD-10 Finland
Multi-infarct dementia
+∞
32.3
31
*
N06AB10
ATC
escitalopram; oral
3.1
32.1
194
683
N05AD03
ATC
melperone; systemic
6.8
31.8
82
125
F01.2
ICD-10 Finland
Subcortical vascular dementia
53.8
31.3
37
7
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.3
31.2
335
1645
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.3
29.6
327
1623
F05.9
ICD-10 Finland
Delirium, unspecified
5.1
28.6
93
190
WYA20
NOMESCO Finland
Home visit
7.1
28.1
70
102
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.2
26.2
313
1601
SPAT1216
SPAT
Assessment of functional ability
2.2
26.0
300
1513
N05AH03
ATC
olanzapine; systemic
6.6
25.0
65
101
F00.20
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms
252.4
24.7
25
*
R41.3
ICD-10 Finland
Other amnesia
5.4
24.4
75
144
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.3
23.7
246
1174
N02BE01
ATC
paracetamol; systemic, rectal
1.8
23.6
1029
8242
L28
ICPC
Limited function/disability (L)
2.1
23.1
316
1705
SPAT1245
SPAT
Provision of support and information to patient’s family members
3.2
23.1
126
412
E86
ICD-10 Finland
Volume depletion
3.9
23.1
97
257
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
2.4
23.0
221
1013
F01.39
ICD-10 Finland
Mixed cortical and subcortical vascular dementia without information on additional symptoms
+∞
22.9
22
*
Z75.5
ICD-10 Finland
Holiday relief care
5.7
21.0
61
110
N05BA06
ATC
lorazepam; systemic, sublingual
3.0
20.2
120
416
F01.3
ICD-10 Finland
Mixed cortical and subcortical vascular dementia
201.1
19.5
20
*
N30.0
ICD-10 Finland
Acute cystitis
2.1
19.5
235
1192
S72.0
ICD-10 Finland
Fracture of neck of femur
2.5
19.1
157
662
G30
ICD-10 Finland
Alzheimer disease
55.4
18.9
22
*
R55
ICD-10 Finland
Syncope and collapse
2.1
18.8
235
1213
R42
ICD-10 Finland
Dizziness and giddiness
1.8
18.6
370
2271
N30.9
ICD-10 Finland
Cystitis, unspecified
2.7
18.6
132
511
130
Kela drug reimbursment
Malignant tumour
0.2
18.6
21
943
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.6
18.5
86
249
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.2
18.5
194
925
F06.7
ICD-10 Finland
Mild cognitive disorder
4.3
18.3
68
161
F01.30
ICD-10 Finland
Mixed cortical and subcortical vascular dementia without additional symptoms
30.2
18.3
24
8
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
3.2
18.0
99
326
G40.9
ICD-10 Finland
Epilepsy, unspecified
4.1
17.7
70
176
F0019, G301
ICD-10 Finland
NA
+∞
17.7
17
*
I95.1
ICD-10 Finland
Orthostatic hypotension
3.1
17.6
100
336
F00.10
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
95.5
17.5
19
*
F01.24
ICD-10 Finland
Subcortical vascular dementia other additional symptoms of mixed type
+∞
16.6
16
*
W19
ICD-10 Finland
Unspecified fall
2.3
16.5
163
754
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
2.2
16.5
174
828
F01.80
ICD-10 Finland
Other specified vascular dementia without additional symptoms
90.5
16.5
18
*
I67.9
ICD-10 Finland
Cerebrovascular disease, unspecified
5.5
16.0
47
87
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
1.7
16.0
365
2324
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
3.6
16.0
72
204
SPAT1360
SPAT
Extensive global examination
2.6
15.5
120
489
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.9
15.3
269
1570
S06.0
ICD-10 Finland
Concussion
2.3
15.2
143
645
B01AC07
ATC
dipyridamole; systemic
1.9
15.1
228
1260
R33
ICD-10 Finland
Retention of urine
2.0
15.0
205
1088
I64
ICD-10 Finland
Stroke, not specified as haemorrhage or infarction
5.1
15.0
47
94
S70.0
ICD-10 Finland
Contusion of hip
2.8
15.0
96
350
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.8
14.8
100
377
J01DB01
ATC
cefalexin; oral
1.6
14.8
857
6915
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.5
14.7
122
516
H02AB02
ATC
dexamethasone; systemic
0.2
14.6
11
635
F009, G309
ICD-10 Finland
NA
+∞
14.6
14
*
SPAT1254
SPAT
Administration of medicine
1.8
14.5
256
1497
I10
ICD-10 Finland
Essential (primary) hypertension
1.5
14.4
895
7321
SPAT1234
SPAT
Support of social functional capacity
2.5
14.4
114
472
NFB20
NOMESCO Finland
Primary partial prosthetic replacement of hip joint using cement, other or unspecified
2.8
14.3
96
361
N02AA05
ATC
oxycodone; systemic
1.8
14.2
278
1679
S01.0
ICD-10 Finland
Open wound of scalp
2.3
14.2
134
605
N06AX16
ATC
venlafaxine; oral
3.0
13.7
83
290
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.6
13.7
444
3096
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
5.3
13.7
41
78
G30.0
ICD-10 Finland
Alzheimer disease with early onset
+∞
13.5
13
*
F02.39*G20
ICD-10 Finland
Dementia in Parkinson's disease without information on additional symptoms
+∞
13.5
13
*
F0029, G308
ICD-10 Finland
NA
+∞
13.5
13
*
K90
ICPC
Stroke/cerebrovascular accident
3.2
13.5
72
233
Z02.4
ICD-10 Finland
Examination for driving licence
0.5
13.3
106
2008
C10AA01
ATC
simvastatin; oral
1.5
13.3
705
5519
A10AE04
ATC
insulin glargine; parenteral
2.2
13.2
144
696
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.8
13.0
229
1333
G91.2
ICD-10 Finland
Normal-pressure hydrocephalus
5.4
12.8
38
72
NE1AA
NOMESCO Finland
Pelvis X-ray examination
2.3
12.8
125
575
4378A
ICD-9 Finland
Other and ill-defined cerebrovascular disease, Other[MULTI-INFARKTIDEMENTIA]
+∞
12.5
12
*
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.8
12.4
255
1559
F00.9
ICD-10 Finland
Dementia in Alzheimer disease, unspecified
130.1
12.4
13
*
XA800
NOMESCO Finland
Neuropsychological investigation
5.8
12.3
34
59
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
2.2
12.2
131
628
E000001
ATC
NA
1.8
12.1
244
1484
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
2.7
12.1
80
300
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.9
12.0
184
1018
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.8
11.8
219
1297
Z3231
NOMESCO Finland
Registered nurse
1.6
11.7
356
2423
K91
ICPC
Cerebrovascular disease
4.9
11.7
37
76
N06AX26
ATC
vortioxetine; oral
4.1
11.5
44
109
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.8
11.5
75
277
2900A
ICD-9 Finland
Senile and presenile organic psychotic conditions, Senile dementia, uncomplicated
+∞
11.4
11
*
J01CA08
ATC
pivmecillinam; oral
1.5
11.4
459
3345
F29
ICD-10 Finland
Unspecified nonorganic psychosis
7.5
11.4
26
35
A04
ICPC
Weakness/tiredness general
1.8
11.3
196
1133
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
7.9
11.3
25
32
G31.8
ICD-10 Finland
Other specified degenerative diseases of nervous system
17.1
11.2
17
10
U04
ICPC
Incontinence urine
2.5
10.8
82
331
Z2445
NOMESCO Finland
Psychologist
6.5
10.7
27
42
J01EA01
ATC
trimethoprim; systemic
1.5
10.7
417
3005
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
3.0
10.7
59
198
F05.8
ICD-10 Finland
Other delirium
6.3
10.6
27
43
I69.8
ICD-10 Finland
Sequelae of other and unspecified cerebrovascular diseases
6.3
10.6
27
43
Z3226
NOMESCO Finland
Physiotherapist
1.7
10.6
230
1425
N05CD07
ATC
temazepam; oral
1.6
10.5
310
2090
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.7
10.4
232
1448
F01.23
ICD-10 Finland
Subcortical vascular dementia other additional symptoms, mainly depression
+∞
10.4
10
*
L89
ICD-10 Finland
Decubitus ulcer and pressure area
3.2
10.3
52
163
F00
ICD-10 Finland
Dementia in Alzheimer disease
32.5
10.3
13
*
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.9
10.2
157
869
N03AF02
ATC
oxcarbazepine; oral
3.7
10.1
43
118
B01AA03
ATC
warfarin; systemic
1.5
9.9
533
4107
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
2.4
9.8
80
338
F07.9
ICD-10 Finland
Unspecified organic personality and behavioural disorder due to brain disease, damage and dysfunction
26.0
9.8
13
5
G04CA02
ATC
tamsulosin; oral
1.5
9.8
462
3461
SPAT1172
SPAT
Guidance concerning hydration
2.7
9.7
65
246
ZXD05
NOMESCO Finland
Urgent procedure
1.5
9.6
416
3059
F0009, G300
ICD-10 Finland
NA
+∞
9.4
9
*
F02.89*G40.9
ICD-10 Finland
Dementia in epilepsy
+∞
9.4
9
*
XF400
NOMESCO Finland
ECG with 12 standard connections
1.6
9.2
293
2007
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.1
9.2
108
542
ZXD35
NOMESCO Finland
Usual procedure
2.7
9.1
59
220
R4110
NOMESCO Finland
Physiotherapy
1.6
9.0
282
1921
X59
ICD-10 Finland
Exposure to unspecified factor
1.8
8.9
169
1005
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
1.9
8.8
138
771
F01.84
ICD-10 Finland
Other specified vascular dementia other mixed symptoms of mixed type
49.9
8.7
10
*
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.2
8.5
85
398
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.4
8.5
557
4416
F22.0
ICD-10 Finland
Delusional disorder
4.8
8.5
27
57
F01.14
ICD-10 Finland
Multi-infarct dementia's other mixed symptoms of mixed type
89.9
8.4
9
*
S72.1
ICD-10 Finland
Pertrochanteric fracture
2.3
8.4
76
340
G04BD07
ATC
tolterodine; oral
1.9
8.4
114
606
SPAT1229
SPAT
Assessment of need for aid
1.8
8.2
130
728
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
1.7
8.2
172
1052
G04BD04
ATC
oxybutynin; oral, transdermal
1.8
8.1
136
775
J01MA02
ATC
ciprofloxacin; systemic
1.4
8.0
549
4375
SPAT1262
SPAT
Handing over of treatment supplies
1.6
8.0
213
1391
S20.2
ICD-10 Finland
Contusion of thorax
2.4
8.0
63
264
SAD01
NOMESCO Finland
Assessment of need for oral health care, standard
2.3
7.9
72
322
SPAT1167
SPAT
Insertion of urinary catheter
2.2
7.8
73
332
SPAT1255
SPAT
Intravenous administration of medicine
2.1
7.8
84
406
T36
ICD-10 Finland
Poisoning by systemic antibiotics
3.7
7.8
32
87
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
0.2
7.7
6
335
I67.2
ICD-10 Finland
Cerebral atherosclerosis
5.0
7.7
23
46
I69.1
ICD-10 Finland
Sequelae of intracerebral haemorrhage
3.5
7.6
33
94
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
2.5
7.6
59
244
R11
ICD-10 Finland
Nausea and vomiting
1.8
7.5
122
688
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
4.0
7.4
28
71
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.7
7.4
150
908
SPAT1251
SPAT
Organisation of medication
2.1
7.4
79
381
F01.89
ICD-10 Finland
Other specified vascular dementia without information on additional symptoms
79.9
7.4
8
*
SAB01
NOMESCO Finland
Restricted oral and dental health check by dental hygienist or dental assistant
2.4
7.4
58
242
Z43.5
ICD-10 Finland
Attention to cystostomy
5.3
7.3
21
40
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
5.1
7.2
21
41
A10BB12
ATC
glimepiride; oral
1.6
7.2
184
1193
8070/3-C34.9
ICD-O-3
Squamous cell carcinoma, NOS, of lung, NOS
0.1
7.1
*
232
C07AB07
ATC
bisoprolol; oral
1.3
7.1
747
6340
A10AE05
ATC
insulin detemir; parenteral
2.2
7.1
72
339
A03FA01
ATC
metoclopramide; systemic, rectal
0.6
7.1
123
1904
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.4
7.1
432
3357
G46.8*I67.9
ICD-10 Finland
Other vascular syndromes of brain in cerebrovascular diseases
12.0
7.0
12
10
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
2.0
7.0
83
421
A10AD05
ATC
insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
2.2
7.0
64
290
A10BA02
ATC
metformin; oral
1.4
6.9
417
3234
N06AX21
ATC
duloxetine; oral
2.1
6.8
75
367
R47.0
ICD-10 Finland
Dysphasia and aphasia
3.7
6.8
28
77
G40.2
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
4.8
6.8
21
44
N03AF01
ATC
carbamazepine; oral, rectal
1.9
6.8
92
491
N05AX12
ATC
aripiprazole; systemic
9.3
6.8
13
14
F01.8
ICD-10 Finland
Other vascular dementia
39.9
6.7
8
*
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
3.7
6.7
27
73
ZXE10
NOMESCO Finland
More than one and less than three hours
1.4
6.7
393
3032
SPAT1279
SPAT
Preparation of immediate hospitalisation
3.1
6.7
34
111
SPAT1153
SPAT
Removal of sutures
0.6
6.6
158
2282
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
3.0
6.6
36
123
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.8
6.6
40
146
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
3.1
6.5
33
107
N39.9
ICD-10 Finland
Disorder of urinary system, unspecified
2.8
6.5
38
135
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.5
6.5
221
1531
Z2221
NOMESCO Finland
Medical doctor
1.4
6.5
291
2134
N06AB03
ATC
fluoxetine; oral
1.8
6.4
102
574
F00.19
ICD-10 Finland
Dementia in Alzheimer's disease with late onset without information about additional symptoms
69.6
6.4
7
*
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
4.2
6.4
22
52
8000/3-C34.9
ICD-O-3
Neoplasm, malignant of lung, NOS
0.2
6.3
7
315
N05AB03
ATC
perphenazine; systemic, rectal
2.7
6.3
39
144
R23.8
ICD-10 Finland
Other and unspecified skin changes
0.5
6.3
52
983
N29
ICPC
Neurological sympt/complt other
3.6
6.3
26
72
R31
ICD-10 Finland
Unspecified haematuria
1.6
6.3
179
1186
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
2.3
6.2
51
221
N05CF01
ATC
zopiclone; oral
1.3
6.2
527
4307
E000003
ATC
NA
2.4
6.1
50
215
103
Kela drug reimbursment
Diabetes, insulin-treated
1.4
6.1
441
3511
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.3
6.1
50
216
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
4.0
6.0
22
55
I63.1
ICD-10 Finland
Cerebral infarction due to embolism of precerebral arteries
2.8
6.0
36
131
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3019309) Folate [Moles/volume] in Red Blood Cells
498
2614
2.26
46.61
2.1
1.9
nmol/l
1019.4
1169.2
3.03
362
1909
(3009466) Valproate [Moles/volume] in Serum or Plasma
55
61
9.20
44.76
3.8
3.0
umol/l
314.5
322.3
0.12
38
49
(3026008) Bacteria identified in Urine by Culture
583
3712
1.85
29.32
5.0
3.8
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
521
3462
1.71
21.21
4.9
4.3
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
442
3020
1.61
15.28
2.4
2.1
u/l
330.2
246.5
0.68
400
2780
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
165
851
2.02
14.82
1.9
1.6
—
—
—
0
0
(3026782) Osmolality of Urine
362
2383
1.64
14.45
4.3
3.1
mosm/kgh2o
576.1
540.6
3.13
309
2027
(40768804) Tissue Pathology biopsy report
189
3155
0.54
14.07
1.8
2.5
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
106
473
2.30
13.76
4.3
4.0
%
1.0
0.9
1.42
99
445
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
105
478
2.25
13.01
4.4
4.0
%
1.5
1.6
0.19
98
449
(3031040) Bacteria [#/volume] in Urine by Automated count
793
6336
1.45
12.45
7.5
5.7
e6/l
7235.9
2057.8
0.35
15
130
(3033705) Calcium.ionized [Moles/volume] in Venous blood
63
230
2.78
12.45
3.3
2.6
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
94
425
2.26
11.85
7.6
4.9
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
764
6135
1.43
11.29
6.9
5.0
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
75
314
2.43
11.27
4.4
4.6
mmol/l
1.2
1.5
1.15
65
280
(3038515) Glucose [Moles/volume] in Venous blood
78
334
2.38
11.15
4.9
3.5
mmol/l
8.3
7.9
0.44
78
326
(3009542) Hematocrit [Volume Fraction] of Blood
804
6538
1.42
10.95
29.4
22.8
%
33.7
35.8
2.90
394
3664
(3008037) Lactate [Moles/volume] in Venous blood
79
349
2.30
10.54
4.8
3.5
mmol/l
1.6
1.8
1.14
79
342
(3052592) Norovirus Ag [Presence] in Stool
17
26
6.53
10.51
1.4
1.2
—
—
—
0
0
(3039000) Anion gap in Blood
58
222
2.64
10.50
4.5
4.9
mmol/l
11.7
11.5
0.25
51
200
(3018572) Chloride [Moles/volume] in Blood
58
222
2.64
10.50
4.5
4.9
mmol/l
105.3
104.7
0.50
51
200
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
132
719
1.89
10.10
1.7
1.5
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
323
2264
1.51
9.43
3.0
2.6
u/l
39.4
39.7
0.02
290
2119
(3023183) Ammonium ion [Moles/volume] in Plasma
45
160
2.83
9.40
1.6
1.8
umol/l
26.3
33.5
0.91
33
127
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
631
5014
1.39
9.38
6.2
6.1
mmol/l
1.2
1.2
1.09
500
4122
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
326
2303
1.50
9.14
1.8
1.8
pmol/l
443.2
6439617.0
0.80
247
1817
(3012544) pH of Venous blood
200
1268
1.64
9.02
3.9
3.1
—
7.4
—
0
7
(3024561) Albumin [Mass/volume] in Serum or Plasma
557
4363
1.39
8.91
4.4
4.1
g/l
32.3
33.3
3.12
466
3952
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
85
1592
0.50
8.87
1.6
1.6
mmol/l
1.3
1.2
0.52
70
1301
(3024891) Influenza virus A+B Ag [Presence] in Specimen
62
267
2.35
8.81
1.2
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
77
364
2.15
8.76
1.4
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
77
364
2.15
8.76
1.4
1.4
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
302
2119
1.50
8.72
2.0
1.9
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
315
2238
1.48
8.54
5.2
4.6
ng/l
156.7
370.6
1.05
292
2058
(3024354) Oxygen [Partial pressure] in Venous blood
166
1017
1.68
8.54
3.6
2.7
kpa
4.4
4.3
0.16
154
956
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
548
4311
1.38
8.45
5.6
4.9
ng/l
378.7
68.8
0.47
420
3507
(3002032) Base excess in Venous blood by calculation
192
1234
1.61
8.18
3.9
3.1
mmol/l
1.8
2.0
0.42
152
937
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
379
2825
1.42
7.93
2.7
2.3
u/l
54.6
59.0
1.36
348
2585
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
551
4377
1.37
7.88
2.5
2.2
pmol/l
88.2
90.2
0.54
301
2294
(3002582) Erythrocytes [#/volume] in Urine
435
3330
1.40
7.79
4.1
3.6
e6/l
92.4
105.2
0.15
347
2630
(3021447) Carbon dioxide [Partial pressure] in Venous blood
191
1241
1.59
7.78
3.9
3.1
kpa
5.7
5.8
0.30
178
1179
(3036481) Cortisol [Moles/volume] in Serum or Plasma
111
630
1.80
7.49
1.8
1.8
nmol/l
401.9
407.4
0.10
94
547
(3041096) Erythrocytes [Presence] in Urine by Automated
305
2212
1.45
7.36
6.4
4.3
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
569
4601
1.34
7.09
15.0
13.1
inr
1.5
1.5
0.04
136
1177
(3044290) Cell count panel - Cerebral spinal fluid
25
75
3.34
7.00
1.4
1.2
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
520
4161
1.34
6.91
3.5
2.9
u/l
72.8
58.8
1.43
433
3680
(3015377) Calcium [Moles/volume] in Serum or Plasma
420
3260
1.37
6.79
2.2
3.1
mmol/l
2.3
2.3
1.95
321
2690
(3000330) Specific gravity of Urine by Test strip
110
645
1.74
6.66
7.0
4.3
—
—
—
0
0
(3003338) MCHC [Mass/volume]
714
6012
1.31
6.53
34.3
27.6
g/l
328.4
329.1
0.92
673
5854
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
914
7959
1.30
6.47
29.5
20.7
mg/l
30.5
30.4
0.04
826
6860
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
26
86
3.03
6.24
1.5
1.3
e6/l
3.2
56.9
0.90
20
73
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
26
86
3.03
6.24
1.5
1.4
e6/l
84.8
452.9
0.97
21
74
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
425
3343
1.35
6.24
2.2
2.1
nmol/l
76.6
80.4
1.77
341
2803
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
584
4815
1.31
6.15
4.1
5.1
umol/l
13.0
13.7
0.54
530
4508
(3018095) Leukocytes [#/volume] in Urine
461
3678
1.33
6.13
4.8
4.1
e6/l
314.7
151.9
0.85
348
2789
(3013826) Glucose [Moles/volume] in Serum or Plasma
661
5547
1.30
6.07
4.9
4.6
mmol/l
7.4
7.0
2.62
604
5202
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
77
419
1.86
6.00
1.3
1.2
—
—
—
0
0
(3002256) Pathology report gross observation
60
1109
0.52
6.00
1.2
1.5
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
87
497
1.77
5.80
1.9
1.7
ug/l
2.8
2.8
0.01
64
404
(4035726)
32
722
0.43
5.63
1.3
1.3
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
472
3841
1.30
5.33
4.0
3.6
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
108
673
1.63
5.26
4.7
3.1
mmol/l
25.5
25.0
0.87
101
648
(3012516) Albumin [Mass/volume] in Urine
200
2691
0.70
5.24
2.6
3.1
mg/l
101.6
262.0
1.70
136
1757
(3005570) Glucose [Moles/volume] in Urine
29
113
2.57
5.20
2.4
1.8
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
204
1475
1.42
4.95
1.9
1.8
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
202
2686
0.71
4.92
2.5
3.0
mmol/l
6.6
6.4
0.26
145
2105
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
157
1092
1.47
4.69
5.7
4.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
16
47
3.39
4.67
1.4
1.3
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
394
3183
1.29
4.62
2.6
2.3
mg/l
3.3
3.3
0.11
306
2652
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
60
334
1.81
4.43
2.0
1.4
%
1.8
1.7
0.22
42
263
(3000850) Epithelial cells [#/volume] in Urine
308
2437
1.31
4.20
3.5
2.8
e6/l
5.9
4.7
0.90
275
2137
(3007853) Bacteria identified in Skin by Aerobe culture
161
1151
1.43
4.18
1.9
1.8
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
923
8296
1.22
4.08
33.4
25.6
mmol/l
4.0
4.0
2.87
854
7948
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
531
4506
1.24
4.07
5.1
5.5
mmol/l
1.2
1.2
0.22
452
3968
(3019550) Sodium [Moles/volume] in Serum or Plasma
922
8291
1.22
4.04
33.3
25.4
mmol/l
139.3
139.1
0.70
860
7959
(3030467) Casts [#/volume] in Urine by Automated count
371
3022
1.28
4.03
4.0
3.5
e6/l
0.4
0.6
1.77
304
2370
(3000963) Hemoglobin [Mass/volume] in Blood
925
8340
1.22
3.88
37.5
30.1
g/l
123.6
126.9
8.51
865
8072
(3010813) Leukocytes [#/volume] in Blood
925
8341
1.22
3.87
37.2
29.9
e9/l
7.8
7.3
3.34
855
7921
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
392
3232
1.26
3.84
6.9
5.0
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
924
8337
1.22
3.82
37.1
29.9
e9/l
232.5
231.1
0.23
860
7967
(3035941) MCH [Entitic mass]
924
8337
1.22
3.82
37.0
29.8
pg
30.2
30.3
1.22
865
8054
(3024731) MCV [Entitic volume]
924
8338
1.22
3.81
37.1
29.8
fl
91.7
92.1
1.09
865
8055
(3026361) Erythrocytes [#/volume] in Blood
924
8338
1.22
3.81
37.2
29.9
e12/l
4.1
4.2
7.06
848
7923
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
198
1493
1.36
3.75
1.9
1.8
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
776
6894
1.21
3.73
4.4
4.7
mu/l
2.0
2.1
1.34
660
5964
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
141
1009
1.42
3.66
2.0
2.4
umol/l
10.7
12.2
0.26
108
851
(36304419) Bacteria [Presence] in Urine
350
2872
1.26
3.55
4.1
3.5
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
261
2067
1.30
3.52
3.2
3.1
mmol/l
2.5
2.5
0.23
199
1728
(3008152) Bicarbonate [Moles/volume] in Arterial blood
107
736
1.47
3.44
3.9
5.7
mmol/l
25.0
24.4
0.82
97
687
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
83
543
1.54
3.39
4.8
7.5
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
24
107
2.24
3.32
4.1
3.2
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
676
5978
1.20
3.28
31.4
25.2
%
14.5
14.3
1.72
632
5758
(3020682) Albumin/Creatinine [Ratio] in Urine
237
2898
0.78
3.16
3.2
3.8
mg/mmol
17.6
11.7
0.55
151
1843
(3028679) Herpes simplex virus Ab [Presence] in Serum
7
11
6.32
3.16
1.1
1.3
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
0
80
0.00
3.14
0.0
1.2
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
174
1325
1.34
3.12
3.5
5.5
kpa
5.0
5.0
0.08
149
1228
(3027801) Oxygen [Partial pressure] in Arterial blood
174
1326
1.33
3.10
3.5
5.5
kpa
11.2
11.2
0.03
148
1230
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
366
3066
1.23
3.06
2.9
2.1
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
174
1330
1.33
3.04
3.5
5.5
mmol/l
2.2
1.3
1.61
120
993
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
64
406
1.58
3.02
2.5
2.2
ug/l
1446.7
687.0
0.42
56
382
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
26
125
2.08
3.01
4.4
4.8
mg/l
12.1
12.6
0.27
21
105
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
27
133
2.03
2.94
3.1
2.4
u/field
2.4
3.0
—
5
36
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
86
586
1.48
2.94
2.8
3.0
mmol/l
23.6
23.9
0.44
79
521
(3037121) Protein [Mass/volume] in Urine
60
378
1.59
2.92
2.1
2.7
g/l
0.3
0.3
0.01
13
149
(3035350) Ketones [Presence] in Urine by Test strip
484
4188
1.20
2.91
5.9
4.4
estimate
0.0
0.0
0.00
81
785
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
78
527
1.49
2.79
2.1
1.9
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
742
6683
1.18
2.79
6.4
6.7
u/l
88.1
85.9
0.29
664
6147
(3003458) Phosphate [Moles/volume] in Serum or Plasma
188
1472
1.30
2.78
3.8
4.2
mmol/l
1.1
1.1
0.01
152
1317
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
115
837
1.39
2.77
3.1
3.4
ng/l
115.9
105.0
0.49
85
693
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
71
472
1.51
2.75
2.2
1.8
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
169
1308
1.31
2.72
4.5
3.4
ng/l
409.9
390.5
0.17
153
1185
(3022217) INR in Platelet poor plasma by Coagulation assay
252
2053
1.25
2.71
31.3
33.4
inr
1.9
1.6
1.03
41
246
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
621
5522
1.18
2.71
3.3
3.7
pmol/l
15.3
15.3
0.15
514
4800
(40761511) CBC panel - Blood by Automated count
861
7866
1.17
2.68
27.0
20.2
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
485
4226
1.19
2.67
6.2
4.5
estimate
0.0
0.0
0.00
77
769
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
156
1199
1.32
2.65
2.6
2.7
ug/l
4.6
5.9
0.61
101
977
(3020891) Body temperature
25
462
0.53
2.64
3.2
4.1
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
208
1665
1.27
2.60
1.7
1.8
s
29.7
30.6
1.20
197
1610
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
61
894
0.66
2.57
1.2
1.2
iu/ml
38.0
38.3
0.01
25
270
(3028707) Methadone [Presence] in Urine by Screen method
5
7
7.09
2.53
1.0
1.1
—
—
—
0
0
(3019060) Gas panel - Arterial blood
109
800
1.37
2.52
3.3
3.7
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
13
50
2.59
2.48
2.6
2.0
u/field
2.6
3.6
—
5
36
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
19
373
0.50
2.44
1.1
1.2
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
20
95
2.10
2.43
2.0
1.3
mosm/kgh2o
286.2
270.5
0.97
13
65
(4010399)
28
485
0.56
2.40
1.3
1.4
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
476
4176
1.18
2.39
9.3
6.1
estimate
0.0
0.0
0.00
79
761
(3004775) Volume in Urine collected for unspecified duration
17
76
2.23
2.39
1.7
2.0
ml
702.2
520.0
0.67
12
40
(3014007) Fractional oxyhemoglobin in Arterial blood
42
655
0.63
2.38
4.1
7.2
%
90.7
93.8
0.86
42
650
(3045414) Leukocytes [Presence] in Urine
17
343
0.49
2.37
2.3
2.2
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
200
1612
1.26
2.37
1.6
2.1
%
1.7
1.8
0.52
150
1397
(1616796) Gas panel - Central venous blood
43
265
1.62
2.34
3.2
4.2
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
8
22
3.61
2.34
1.1
1.0
—
—
—
0
0
(3009343) pH of Capillary blood
101
742
1.37
2.34
2.8
3.9
ph
7.4
7.4
—
10
78
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
14
58
2.40
2.32
1.5
1.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
9
214
0.41
2.31
3.1
2.5
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
98
718
1.37
2.31
2.8
3.9
mmol/l
2.4
2.0
0.51
66
521
(3006270) Folate [Moles/volume] in Blood
24
126
1.90
2.25
1.3
1.3
nmol/l
306.9
326.2
0.15
19
93
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
0
61
0.00
2.23
0.0
1.4
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
11
254
0.43
2.22
2.7
2.9
u/ml
27.4
100.0
2.37
11
243
(3022096) Basophils/100 leukocytes in Blood
432
3787
1.17
2.17
4.2
4.9
%
0.5
0.6
1.97
375
3441
(3002030) Lymphocytes/100 leukocytes in Blood
452
3978
1.17
2.16
4.6
5.3
%
22.5
23.5
0.78
386
3593
(3012095) Magnesium [Moles/volume] in Serum or Plasma
197
1606
1.24
2.13
2.1
2.4
mmol/l
0.8
0.8
0.53
163
1433
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
59
833
0.69
2.10
1.2
1.2
u/ml
7.6
14.4
0.53
17
264
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
0
57
0.00
2.05
0.0
1.1
—
3.1
—
0
8
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
7
20
3.48
2.03
1.1
1.2
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
8
26
3.06
1.99
1.5
1.1
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
72
517
1.40
1.95
1.4
1.4
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
66
467
1.42
1.94
3.7
3.2
nmol/l
0.8
0.9
0.60
45
364
(40768797) Stomach Pathology biopsy report
77
1019
0.74
1.88
1.2
1.3
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
0
51
0.00
1.88
0.0
1.1
—
74.9
—
0
7
(3017143) Hepatitis C virus Ab [Presence] in Serum
62
437
1.42
1.88
1.6
1.4
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
209
1742
1.21
1.85
3.4
3.2
e6/l
5.9
2.3
1.53
121
995
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
99
755
1.32
1.85
2.9
3.9
kpa
5.2
5.2
0.01
80
693
(40757373) Influenza virus identified in Isolate
8
28
2.84
1.84
1.4
1.5
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
6
17
3.50
1.82
1.2
1.3
—
—
—
0
0
(4034850)
12
246
0.48
1.81
25.8
14.5
—
—
—
0
0
(3018418) pH of Serum or Plasma
341
2975
1.17
1.81
3.5
3.6
ph
7.4
7.4
0.51
62
574
(3000764) Benzodiazepines [Presence] in Urine
5
12
4.14
1.81
1.0
1.2
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
439
3905
1.15
1.80
4.6
5.0
%
62.1
60.8
1.10
382
3556
(3000570) Elastase.pancreatic [Mass/mass] in Stool
38
245
1.55
1.78
1.7
1.4
ug/g
263.7
258.8
0.06
22
152
(3023410) Appearance of Cerebral spinal fluid
9
35
2.56
1.78
1.6
1.2
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
437
3892
1.15
1.76
4.1
4.9
%
2.8
2.7
0.31
377
3537
(3019069) Monocytes/100 leukocytes in Blood
438
3908
1.15
1.72
4.4
5.2
%
8.9
9.1
0.78
376
3557
(3044889) 12 lead EKG panel
526
5688
0.88
1.71
4.4
4.7
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
38
248
1.53
1.70
2.2
2.8
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
5
13
3.82
1.70
1.0
1.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
5
13
3.82
1.70
1.0
1.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
5
13
3.82
1.70
1.0
1.2
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
13
61
2.12
1.68
1.2
1.0
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
145
1178
1.24
1.66
3.7
5.7
%
94.0
94.7
0.36
130
1117
(3012501) Base excess in Blood by calculation
42
283
1.48
1.63
4.2
4.8
mmol/l
2.7
2.8
0.06
31
182
(3033658) Prothrombin time (PT) actual/Normal
269
2327
1.17
1.59
3.2
3.9
%
74.6
76.7
0.58
257
2252
(3013707) Erythrocyte sedimentation rate by Westergren method
650
5977
1.13
1.58
3.8
4.1
mm/h
19.3
18.1
0.81
554
5368
(40768800) Prostate Pathology biopsy report
11
220
0.49
1.58
1.1
1.1
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
42
0.00
1.52
0.0
3.1
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
44
0.00
1.51
0.0
1.1
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
45
0.00
1.49
0.0
1.0
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
9
37
2.42
1.47
1.7
1.1
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
35
233
1.50
1.46
1.4
1.3
mmol/l
48.2
59.7
1.25
29
184
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
83
1043
0.78
1.45
3.8
4.6
%
34.7
33.9
0.22
50
654
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
641
6795
0.89
1.45
3.6
4.4
mmol/l
1.3
1.4
3.85
538
5871
(3008116) Ketones [Moles/volume] in Urine by Test strip
5
16
3.10
1.42
1.0
1.2
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
11
52
2.10
1.41
1.4
1.2
—
2.8
—
0
5
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
20
117
1.70
1.41
1.9
1.6
—
—
—
0
0
(4094501)
6
134
0.44
1.40
1.0
1.1
—
—
—
0
0
(44806420)
12
59
2.02
1.40
2.4
2.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
143
1683
0.83
1.39
1.3
1.3
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
9
40
2.23
1.39
1.2
1.3
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
33
220
1.50
1.38
1.5
1.5
e6/l
19230.0
21002.3
0.08
22
152
(3000492) Spirometry study
37
521
0.70
1.38
1.4
1.5
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
14
74
1.88
1.35
2.5
2.5
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
340
3033
1.14
1.33
2.2
2.7
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
22
340
0.64
1.31
1.5
1.6
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
8
33
2.41
1.30
1.3
1.0
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
654
6895
0.90
1.30
3.6
4.5
mmol/l
4.0
4.2
5.84
553
6057
(3013139) Helicobacter pylori Ag [Presence] in Stool
27
398
0.67
1.29
1.1
1.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
50
367
1.36
1.27
4.0
3.9
—
—
—
0
0
(3022145) Colonoscopy Study observation
54
704
0.75
1.27
1.2
1.3
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
6
25
2.38
1.23
1.5
1.2
iu/ml
292.2
145.5
—
6
25
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
103
839
1.23
1.21
3.8
3.6
mmol/l
1.2
1.2
0.56
87
721
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
28
187
1.49
1.19
1.9
1.5
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
35
245
1.42
1.18
2.5
2.6
%
15.4
14.9
0.34
17
121
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
6
26
2.29
1.17
1.2
1.2
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
6
126
0.47
1.17
1.2
1.6
ug/l
14.2
21.6
—
6
121
(40768793) Breast Pathology biopsy report
6
126
0.47
1.17
1.5
1.3
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
33
0.00
1.16
0.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
33
0.00
1.16
0.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
33
0.00
1.16
0.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
33
0.00
1.16
0.0
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
33
0.00
1.16
0.0
1.1
—
—
—
0
0
(4015189)
0
33
0.00
1.16
0.0
2.5
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
33
0.00
1.16
0.0
1.1
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
0
33
0.00
1.16
0.0
1.3
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
690
7223
0.91
1.16
4.1
5.1
mmol/l
2.2
2.4
5.17
589
6275
(3019150) Specific gravity of Urine by Refractometry
217
1898
1.15
1.15
6.0
5.0
kg/l
1.0
1.0
0.22
64
333
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
0
35
0.00
1.15
0.0
1.2
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
850
8033
1.10
1.13
9.6
10.6
u/l
21.8
23.0
0.60
777
7558
(3032057) Clostridioides difficile [Presence] in Stool
7
30
2.32
1.12
3.7
1.7
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
14
80
1.74
1.09
1.3
1.3
e6/l
41917.0
148284.9
—
5
52
(3016650) Hepatitis A virus Ab [Presence] in Serum
11
58
1.88
1.09
1.1
1.0
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
9
163
0.54
1.08
1.7
1.5
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
15
88
1.69
1.08
26.6
21.2
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
165
1423
1.16
1.07
2.4
1.8
—
—
—
0
0
(4062490)
9
45
1.99
1.04
1.4
1.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
9
46
1.94
1.03
1.4
2.8
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
22
145
1.51
1.02
3.4
3.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
142
1621
0.86
1.02
3.7
3.6
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
120
1014
1.19
1.00
4.2
6.2
g/l
120.1
116.9
0.93
113
977
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
7
130
0.53
0.99
1.0
1.1
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
0
28
0.00
0.98
0.0
1.1
—
0.7
—
0
10
(40765096) Chromosome analysis panel by Banding
0
29
0.00
0.97
0.0
1.0
—
—
—
0
0
(3036489) Thrombin time
15
233
0.63
0.96
1.6
1.8
s
23.3
21.6
0.51
15
216
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
100
835
1.20
0.96
2.0
2.4
u/l
26.9
34.6
1.51
83
697
(3019832) Treponema pallidum Ab [Presence] in Serum
18
115
1.56
0.96
1.1
1.1
—
—
—
0
0
(3042010) Triglyceride [Moles/volume] in Pleural fluid
0
32
0.00
0.94
0.0
1.1
—
1.0
—
0
18
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
6
116
0.51
0.94
1.0
1.2
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
319
2900
1.11
0.93
3.5
4.7
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
12
70
1.70
0.90
1.1
1.1
—
—
—
0
0
(4024509)
5
102
0.48
0.89
1.2
1.7
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
28
201
1.39
0.87
1.7
1.3
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
12
191
0.62
0.87
1.3
1.4
—
—
—
0
0
(40768443) Skin Pathology biopsy report
31
410
0.74
0.87
1.2
1.2
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
632
6573
0.92
0.85
3.3
4.0
mmol/l
1.2
1.2
0.06
528
5622
(3022313) Gas panel - Capillary blood
68
556
1.22
0.83
2.8
3.9
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
6
32
1.86
0.81
1.2
1.0
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
6
32
1.86
0.81
1.7
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
6
32
1.86
0.81
1.7
1.1
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
122
1055
1.16
0.80
1.9
2.2
g/l
64.9
65.2
0.16
96
919
(3004716) Salmonella sp identified in Stool by Organism specific culture
32
239
1.33
0.80
1.4
1.3
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
26
188
1.38
0.79
2.3
2.0
mmol/l
2.0
1.7
0.68
26
182
(3037522) Nuclear Ab [Titer] in Serum
60
720
0.82
0.79
1.2
1.2
titre
772.0
531.8
—
10
170
(3044007) Cell count panel - Peritoneal fluid
0
24
0.00
0.79
0.0
1.2
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
25
0.00
0.79
0.0
1.4
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
0
25
0.00
0.79
0.0
1.0
—
5.1
—
0
11
(3004588) Protein electrophoresis panel - Serum or Plasma
103
881
1.17
0.79
1.9
2.1
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
62
506
1.22
0.78
2.2
2.2
g/l
8.3
7.7
0.95
33
357
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
14
89
1.56
0.78
1.2
1.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
14
89
1.56
0.78
1.2
1.3
—
—
—
0
0
(3019225) pH of Specimen
116
1002
1.16
0.78
5.4
4.7
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
0
26
0.00
0.78
0.0
1.0
—
1.1
—
0
11
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
26
0.00
0.78
0.0
5.6
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
30
223
1.34
0.78
1.5
1.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
100
1144
0.86
0.78
2.2
3.3
ug/l
28.7
28.6
0.00
79
980
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
55
444
1.23
0.77
1.5
1.3
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
330
3510
0.91
0.76
11.1
10.6
e9/l
0.0
0.0
0.04
250
2779
(40758558) Short blood count panel - Blood
195
2125
0.90
0.73
4.8
5.8
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
12
182
0.65
0.73
1.2
1.3
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
14
205
0.67
0.72
1.3
1.4
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
25
1.98
0.72
1.4
1.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
86
733
1.17
0.70
5.8
4.6
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
19
133
1.42
0.70
1.4
1.3
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
46
369
1.24
0.70
1.4
1.6
g/l
0.9
1.5
1.67
41
325
(3025159) Blasts/100 leukocytes in Blood
48
580
0.81
0.70
2.1
3.7
%
0.2
0.1
—
9
173
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
61
505
1.20
0.69
2.2
2.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
10
155
0.64
0.68
1.4
1.4
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
5
27
1.84
0.68
1.2
1.1
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
504
4747
1.07
0.67
5.2
7.1
e9/l
5.1
4.6
2.77
404
4027
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
39
479
0.80
0.66
1.8
1.5
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
448
4204
1.08
0.66
4.0
4.8
e9/l
0.2
0.2
0.52
362
3542
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
5
28
1.77
0.65
2.4
2.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
29
222
1.30
0.64
1.5
1.2
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
23
170
1.34
0.64
5.4
14.7
mmol/l
6.5
7.2
0.68
16
141
(3042111) Morphology [Interpretation] in Bone marrow Narrative
15
210
0.70
0.63
1.1
1.4
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
208
1896
1.10
0.61
2.3
2.4
umol/l
10.1
10.9
0.81
176
1715
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
60
503
1.19
0.61
2.2
2.2
g/l
3.4
3.8
0.84
32
342
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
98
855
1.14
0.61
1.7
1.8
g/l
0.2
0.2
1.77
78
776
(40761535) Cells panel - Urine sediment
78
888
0.86
0.61
4.3
3.8
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
394
3695
1.07
0.59
3.0
2.9
ug/l
154.4
155.6
0.03
334
3254
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
42
503
0.82
0.59
1.3
1.2
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
14
195
0.71
0.58
1.5
1.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
186
2002
0.91
0.58
5.3
4.4
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
443
4180
1.07
0.56
4.2
4.8
e9/l
1.8
1.7
0.21
361
3534
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
8
122
0.65
0.54
1.5
1.5
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
36
291
1.23
0.54
1.5
1.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
196
2097
0.92
0.54
2.8
3.4
ug/l
0.8
0.9
2.70
127
1521
(3023520) Reticulocytes [#/volume] in Blood
130
1166
1.11
0.54
1.9
2.2
e9/l
61.9
66.3
0.97
93
900
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
22
167
1.31
0.54
2.5
2.5
mg/l
30.6
28.4
—
9
37
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
28
220
1.26
0.53
1.5
1.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
17
124
1.36
0.53
1.3
1.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
9
62
1.44
0.52
1.3
1.6
—
—
—
0
0
(1002224) Polysomnography panel
6
96
0.62
0.52
1.0
1.0
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
9
63
1.42
0.51
1.0
1.0
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
17
125
1.35
0.51
1.5
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
17
126
1.34
0.49
1.5
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
17
126
1.34
0.49
1.5
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
17
126
1.34
0.49
1.5
1.3
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
52
442
1.17
0.49
3.2
4.4
mmol/l
25.3
24.8
0.82
35
397
(3026389) Candida sp identified in Specimen by Organism specific culture
13
92
1.40
0.48
1.2
1.3
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
7
109
0.63
0.48
1.4
1.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
389
3676
1.06
0.48
4.3
5.8
ug/l
6.0
7.3
0.21
308
3178
(3013512) EKG study
317
2976
1.07
0.48
6.0
5.0
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
120
1083
1.10
0.46
4.2
4.8
mmol/l
14.4
13.6
0.38
97
992
(3024928) Oxygen saturation in Venous blood
29
234
1.23
0.46
1.7
2.0
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
54
463
1.16
0.46
2.9
2.3
g/l
12.4
11.1
0.43
46
409
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
11
76
1.44
0.46
2.8
3.9
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
71
792
0.88
0.45
1.5
1.4
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
68
1.46
0.45
1.2
1.4
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
284
2663
1.07
0.45
1.7
1.6
nmol/l
17.8
19.5
1.04
240
2215
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
196
1816
1.08
0.43
3.1
3.0
e6/l
1.4
1.6
0.24
108
1058
(3006315) Basophils [#/volume] in Blood
431
4098
1.06
0.43
3.8
4.6
e9/l
0.0
0.0
0.07
350
3393
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
15
112
1.33
0.42
1.4
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
60
523
1.14
0.42
2.7
2.4
u/ml
0.3
0.4
2.03
32
309
(3051611) Lipemic interference index of Serum or Plasma
10
138
0.72
0.42
2.2
3.9
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
36
301
1.19
0.42
2.6
2.4
—
4.5
—
0
6
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
416
3959
1.05
0.41
3.9
4.5
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
17
0.00
0.40
0.0
1.3
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
17
0.00
0.40
0.0
1.4
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
106
1146
0.91
0.40
17.9
10.4
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
49
554
0.87
0.39
1.5
1.7
ug/g
419.0
179.7
1.07
39
418
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
17
213
0.79
0.39
1.0
1.1
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
12
158
0.75
0.39
1.7
2.0
%
100.3
82.4
2.01
12
149
(3051101) Glucose [Moles/volume] in Cord blood
5
35
1.42
0.39
6.2
5.6
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
62
689
0.89
0.39
2.2
3.6
%
1.9
0.9
0.62
15
234
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
0
19
0.00
0.39
0.0
1.1
—
1.0
—
0
14
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
20
159
1.25
0.37
1.3
1.3
g/l
1.2
1.1
0.30
15
149
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
36
415
0.86
0.37
2.0
2.6
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
47
407
1.15
0.37
1.2
1.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
137
1458
0.92
0.37
3.3
4.1
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
128
1366
0.92
0.37
2.2
3.1
u/l
244.4
250.4
0.35
114
1261
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
28
232
1.20
0.37
1.8
2.2
ug/min
106.8
112.0
0.03
15
137
(3051651) Icteric interference index of Serum or Plasma
9
69
1.29
0.37
2.2
3.8
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
426
4072
1.05
0.36
3.8
4.6
e9/l
0.7
0.7
1.10
341
3359
(3014576) Chloride [Moles/volume] in Serum or Plasma
150
1390
1.08
0.35
4.0
5.7
mmol/l
104.8
103.9
1.04
144
1351
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
725
7347
0.96
0.35
4.4
5.2
mmol/l
6.3
6.2
1.24
589
6299
(3002179) Metamyelocytes/100 leukocytes in Blood
54
600
0.89
0.35
1.9
3.5
%
0.7
0.6
—
8
161
(3024522) Salmonella sp identified in Specimen by Organism specific culture
16
125
1.27
0.35
1.4
1.3
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
16
127
1.25
0.31
3.2
2.8
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
24
281
0.84
0.31
1.7
1.5
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
180
1688
1.06
0.31
2.4
2.4
%
19.2
19.9
0.26
135
1427
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
35
302
1.15
0.31
2.2
2.5
pmol/l
4.3
4.2
0.19
25
250
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
7
99
0.70
0.30
1.1
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
10
129
0.77
0.29
1.1
1.3
—
—
—
0
0
(3024263) Appearance of Synovial fluid
7
56
1.24
0.29
1.6
1.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
20
165
1.20
0.29
1.4
1.4
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
19
156
1.21
0.29
1.3
1.2
g/l
0.2
0.2
0.13
14
149
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
37
323
1.14
0.28
1.7
1.5
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
34
295
1.14
0.28
1.1
1.4
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
13
102
1.26
0.28
1.3
1.5
%
73.9
67.5
—
8
70
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
8
62
1.28
0.28
1.1
1.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
8
62
1.28
0.28
1.1
1.2
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
53
475
1.11
0.27
2.2
2.2
g/l
10.6
10.4
0.07
39
385
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
8
65
1.22
0.27
1.0
1.0
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
10
76
1.31
0.26
2.8
1.8
—
1822.7
—
0
9
(3023199) Leukocytes [#/volume] in Pleural fluid
21
244
0.85
0.26
1.3
1.4
e6/l
1520.7
1318.5
0.10
16
182
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
67
610
1.09
0.26
3.3
6.8
mmol/l
25.1
24.5
0.75
53
539
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
5
71
0.70
0.26
1.2
1.4
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
5
71
0.70
0.26
1.2
1.4
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
5
71
0.70
0.26
1.2
1.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
5
73
0.68
0.26
1.6
1.3
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
105
977
1.07
0.25
2.9
5.2
mmol/l
1.5
1.5
0.07
93
907
(3000012) Reticulocyte production index
9
75
1.19
0.24
1.3
1.6
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
9
76
1.17
0.24
1.2
1.3
nmol/l
0.7
0.7
—
9
66
(40760888) Immunoglobulin light chains.free panel - Serum
35
309
1.12
0.24
1.9
3.0
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
18
210
0.85
0.24
1.8
1.7
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
17
142
1.19
0.22
1.0
1.1
—
19.3
—
0
6
(3014891) Appearance of Pleural fluid
5
39
1.27
0.22
1.4
1.6
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
188
1787
1.05
0.22
2.3
2.3
g/l
2.1
2.2
2.54
159
1608
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
7
91
0.76
0.22
1.1
1.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
15
124
1.20
0.22
1.8
2.8
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
18
208
0.86
0.22
1.6
1.5
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
1903.0
—
0
10
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.7
—
35.6
—
0
5
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
3.2
—
1.2
—
0
10
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
11
0.00
0.21
0.0
1.7
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
5
42
1.18
0.21
3.6
4.8
%
54.8
53.2
—
5
37
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
12
0.00
0.21
0.0
5.1
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
8
101
0.78
0.21
1.0
1.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
8
103
0.77
0.21
1.4
1.5
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
0
13
0.00
0.20
0.0
1.5
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
13
0.00
0.20
0.0
1.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
45
409
1.09
0.20
1.7
1.3
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
11
132
0.82
0.19
1.8
2.5
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
61
648
0.93
0.19
2.2
3.6
%
0.1
0.1
0.25
15
217
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
6
50
1.19
0.19
2.8
1.2
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
15
126
1.18
0.19
1.4
1.2
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
6
51
1.17
0.19
1.2
4.4
u/l
259.0
226.2
—
6
51
(3007566) Smooth muscle Ab [Titer] in Serum
16
136
1.17
0.18
1.3
1.1
—
103.3
—
0
9
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
7
59
1.18
0.18
1.1
1.2
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
17
146
1.15
0.17
1.2
1.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
28
250
1.11
0.17
1.4
1.3
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
5
67
0.74
0.17
1.4
1.3
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
302
2920
1.03
0.16
4.3
5.0
%
20.7
22.8
1.32
111
1611
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
8
67
1.18
0.16
1.1
1.3
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
17
192
0.88
0.16
2.2
3.6
%
1.1
1.5
—
8
130
(3000991) Gas panel - Venous blood
102
965
1.05
0.16
4.0
5.9
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
8
69
1.15
0.16
1.3
1.3
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
8
69
1.15
0.16
1.4
1.5
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
8
70
1.13
0.16
1.0
1.2
u/ml
—
—
—
0
0
(3011648) Oxygen content in Venous blood
8
71
1.12
0.16
1.4
1.3
%
9.5
10.3
—
8
71
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
8
72
1.10
0.15
1.0
1.9
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
13
110
1.17
0.15
1.2
1.9
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
9
78
1.14
0.15
1.3
1.5
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
709
7107
0.98
0.15
7.0
6.9
mmol/mol
44.4
42.4
4.03
601
6264
(3017732) Neutrophils [#/volume] in Blood
57
532
1.06
0.14
3.0
3.2
e9/l
4.4
4.3
0.10
39
335
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
7
85
0.81
0.14
1.4
1.5
—
—
—
0
0
(3035880) pH of Pleural fluid
13
111
1.16
0.14
1.0
1.4
—
—
—
0
0
(4146454)
12
102
1.17
0.13
2.3
2.8
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
22
197
1.11
0.13
1.4
1.5
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
9
108
0.82
0.13
1.0
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
71
671
1.05
0.13
5.1
3.8
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
234
2370
0.97
0.12
2.3
2.9
umol/l
4908.2
9677.4
0.87
176
1917
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
50
468
1.06
0.12
2.2
2.2
g/l
3.1
3.3
0.49
32
352
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
184
1778
1.03
0.12
1.6
1.6
mg/l
1.5
1.7
0.25
143
1395
(3034860) Kappa light chains.free [Mass/volume] in Serum
45
421
1.06
0.11
1.8
2.9
mg/l
92.4
88.2
0.05
31
345
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
10
85
1.17
0.11
1.5
1.6
%
82.2
67.4
—
5
65
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
39
364
1.06
0.10
1.7
2.3
g/l
0.3
0.1
0.28
28
317
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
6
53
1.12
0.09
1.0
1.2
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
6
55
1.08
0.08
1.3
1.5
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
5
60
0.82
0.08
1.4
1.3
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
5
63
0.79
0.08
5.2
2.3
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
7
68
1.02
0.07
1.4
1.5
—
—
—
0
0
(3004451) EKG impression Narrative
6
70
0.85
0.07
1.3
1.2
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
14
152
0.91
0.07
1.5
1.7
%
60.2
59.1
0.05
14
152
(3011985) Renin [Units/volume] in Plasma
8
73
1.09
0.07
1.4
1.1
mu/l
37.4
71.0
—
8
58
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
67
643
1.03
0.07
2.4
2.6
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
16
146
1.09
0.07
1.9
2.7
e9/l
5.5
4.8
0.49
16
146
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
9
99
0.90
0.06
1.2
1.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
63
643
0.97
0.06
4.3
3.3
ml/min/173m2
58.5
53.1
0.62
31
321
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
426
4186
1.01
0.06
3.4
3.5
ng/l
3060.7
2800.9
0.43
347
3676
(3003434) Protein [Mass/volume] in Pleural fluid
27
281
0.95
0.05
1.4
1.5
g/l
27.5
27.7
0.02
22
248
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
224
2245
0.99
0.05
2.0
2.5
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
44
421
1.04
0.05
1.8
2.9
mg/l
85.3
52.4
0.29
29
348
(3007164) IgA [Mass/volume] in Serum or Plasma
107
1079
0.98
0.05
1.4
1.3
g/l
3.3
2.8
0.43
58
577
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
70
679
1.02
0.04
1.1
1.6
g/l
1.7
1.5
0.82
53
567
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
41
394
1.03
0.04
1.6
2.2
g/l
35.8
35.9
0.03
26
316
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
709
7001
1.01
0.03
26.2
20.4
ml/min/173m2
61.7
62.4
0.36
574
5891
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
136
0.95
0.02
1.2
1.4
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
11
116
0.94
0.02
1.7
4.1
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
43
418
1.02
0.01
1.6
2.3
g/l
1.2
1.2
0.00
29
338
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
13
122
1.06
0.01
1.2
1.4
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
16
152
1.04
0.01
1.9
3.2
%
67.4
63.0
0.79
16
152
(3029937) Albumin [Presence] in Urine by Test strip
229
2277
1.00
0.01
6.0
4.8
estimate
0.0
0.0
0.00
68
713
(3049717) Cytology report of Urine Cyto stain
54
542
0.99
0.01
2.5
2.9
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
12
114
1.04
0.00
1.3
1.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
12
114
1.04
0.00
1.2
1.4
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
35
345
1.00
0.00
1.7
2.4
g/l
0.0
0.0
0.50
25
299
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
34
342
0.98
0.00
1.7
2.4
g/l
0.0
0.0
0.00
25
298
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
19
183
1.03
0.00
1.3
1.5
iu/ml
20.2
0.4
—
8
53
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
121
1194
1.00
0.00
1.2
1.2
u/ml
2.0
1.5
0.20
22
276
(3042631) Mycobacterium sp identified in Specimen
16
161
0.98
0.00
2.4
3.0
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
85
838
1.00
0.00
1.9
1.8
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
15
144
1.03
0.00
1.5
1.5
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
5
54
0.92
0.00
1.4
1.5
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3023383) Lactate [Moles/volume] in Pleural fluid
5
54
0.92
0.00
1.0
1.3
mmol/l
2.3
3.1
—
5
47
(3013293) Extractable nuclear Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
6
65
0.91
0.00
1.3
2.7
—
—
—
0
0
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
5.9
—
0
7
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
7.3
—
0.7
—
0
6
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.0
—
1.8
—
0
7
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
5
56
0.88
0.00
1.4
1.5
mu/l
553.6
354.0
—
5
51
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
7
77
0.90
0.00
1.3
1.4
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
5.1
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
7
74
0.94
0.00
1.1
2.6
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.7
—
112.0
—
0
6
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3017704) Immunofixation for Urine
6
68
0.87
0.00
1.0
1.5
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
9
96
0.93
0.00
1.4
1.4
—
—
—
0
0
(3000919) Neutrophils/100 leukocytes in Pleural fluid
5
59
0.84
0.00
2.0
1.5
%
10.1
19.4
—
5
50
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
0
7
0.00
0.00
0.0
2.7
—
242.3
—
0
7
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
7
78
0.89
0.00
1.0
1.1
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
7
0.00
0.00
0.0
2.9
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
7
77
0.90
0.00
1.3
1.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
8
89
0.89
0.00
1.1
1.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
7
74
0.94
0.00
1.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint VD_U and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| VD_U | 2.788 [2.44, 3.19] | < 0.001 |
| Birth year | 0.997 [0.99, 1.0] | 0.403 |
During the follow-up period (1.1.1998 — 31.12.2019), 8245 out of 10204 females with VD_U died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| VD_U | 3.498 [2.89, 4.24] | < 0.001 |
| Birth year | 0.989 [0.98, 1.0] | 0.009 |
During the follow-up period (1.1.1998 — 31.12.2019), 5642 out of 6992 males with VD_U died.
Mortality risk
Mortality risk for people of age
years, who have VD_U.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.305% | 0.651% |
| 5 | 1.807% | 4.251% |
| 10 | 4.236% | 9.817% |
| 15 | 8.247% | 18.241% |
| 20 | 13.913% | 30.207% |
Relationships between endpoints
↥Index endpoint: VD_U – Vascular dementia (undefined)
GWS hits: 4
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data